5 completed, 1 terminated, 1 unknown. 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Arthropathy, Neurogenic: new trials by email Literature Review of Arthropathy, Neurogenic trials Research Report on Arthropathy, Neurogenic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zoledronic Acid or Methylprednisolone for Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes Mellitus Zoledronic Acid, Methylprednisolone, Placebos - Charcot Arthropathy, Diabetes Complications | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 36 | 2016-06-01 | 2019-07-16 |
| Characterization of Local and Systemic Bone Markers in Diabetes Patients With Charcot Osteoarthropathy Blood sample measurements - Arthropathy, Neurogenic, Diabetes Complications | Completed | Bispebjerg Hospital | 5 | 2015-02-01 | 2020-03-31 | |
| Characterization of the Charcot Foot Charcot's Joint, Complications of Diabetes Mellitus | Completed | Bispebjerg Hospital | 21 | 2014-09-01 | 2020-03-31 | |
| Genetic Contribution to the Pathophysiology of the Charcot Foot in Qatari Patients With Diabetes Charcot Arthropathy, Type 2 Diabetes | Completed | Weill Medical College of Cornell University | 57 | 2013-12-01 | 2020-01-14 | |
| Neurogenic Inflammation in Diabetes Intracutaneous injection of Candida albicans antigen., Temperature measurement. - Diabetes Mellitus, Polyneuropathies | Not applicable | Completed | Maastricht University Medical Center | 41 | 2012-05-01 | 2015-05-06 |
| Characterizing and Diagnosis's of the Charcot Foot (Charcot Osteoarthropathy) in Diabetic Patients Charcot Joint, Diabetic Foot | Unknown | Bispebjerg Hospital | 50 | 2005-05-01 | 2005-12-08 | |
| Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease anakinra - Nervous System Malformations, Arthropathy, Neurogenic | Phase 1 / Phase 2 | Terminated | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 43 | 2003-09-01 | 2016-12-01 |
Diabetes Complications (3) · Diabetes Mellitus (2) · Congenital Abnormalities (1) · Cryopyrin-Associated Periodic Syndromes (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Foot (1) · Joint Diseases (1) · Nervous System Malformations (1) · Osteoporosis (1) · Papilledema (1) · Polyneuropathies (1) · Urticaria (1)
Musculoskeletal Diseases (7) · Endocrine System Diseases (6) · Joint Diseases (6) · Diabetes Mellitus (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Glucose Metabolism Disorders (3) · Nervous System Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Chronic Inducible Urticaria (1)
Interleukin 1 Receptor Antagonist Protein (1) · Methylprednisolone (1) · Zoledronic Acid (1)
Bispebjerg Hospital (3) · Maastricht University Medical Center (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · Weill Medical College of Cornell University (1)
Denmark (2) · India (1) · Netherlands (1) · Qatar (1) · United States (1)
Anil Bhansali, DM (1) · Charbel Abi Khalil, MD (1) · Nicolaas Schaper, MD, PhD (1) · Ole L Svendsen, M.D (1) · Raphaela T Goldbach-Mansky, M.D. (1) · Rasmus B Jansen, MD (1)
PMID 16899778, PMID 22294344, PMID 25223501, PMID 27143789, PMID 28118536, PMID 29869523, PMID 31557355, PMID 34748565
ZIAAR041138-08 (1)